Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FBEE4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,812
Award facts
- Contract value 100% obligated
- $40,811.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of RINVOQ ER 30 mg tablets (30-unit packages) with a contract ceiling value of $40,811.72. This firm fixed-price delivery order, which closes on August 7, 2025, represents a competitive award with no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical procurement supporting military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, continues to fulfill essential medication supply requirements for the Defense Health Agency and broader military medical supply chain through this delivery order. RINVOQ ER is a prescription immunosuppressant used in rheumatoid arthritis treatment, reflecting the company's established portfolio of specialty medications and therapeutic products supporting federal healthcare operations. The competitive award validates AmerisourceBergen's capability to meet federal procurement standards while serving multiple customer agencies including the U.S. Coast Guard and other government healthcare systems through the comprehensive DLA vehicle.
Quick answers
Who was awarded contract SPE2DB25FBEE4?
SPE2DB25FBEE4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FBEE4 worth?
The government has obligated $40,812 on SPE2DB25FBEE4.
Is contract SPE2DB25FBEE4 an order under another contract?
Yes. SPE2DB25FBEE4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBEE4 competed?
The extent of competition for SPE2DB25FBEE4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award